Ms Ashley Whitechurch
Clinical (Lecturer)
The Sir Peter MacCallum Department of Oncology
13 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial
DOI: 10.1093/infdis/jiaf2972025
Journal article
Recommendations for innovation in vaccination services for adults with haematological malignancies: an Australian cross-sectional survey study
DOI: 10.1016/j.vaccine.2025.1275392025
Journal article
A single-institution study of allograft outcomes for chronic lymphocytic leukaemia over 20 years
DOI: 10.1111/imj.701242025
Journal article
“It's a risk-benefit analysis”: Qualitative perspectives on barriers and enablers to post-treatment vaccination from adults affected by a haematological malignancy in Australia
DOI: 10.1016/j.vaccine.2025.1268262025
Journal article
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers
DOI: 10.1111/cts.701442025
Journal article
Influenza Vaccination Strategies in Patients with Hematologic Cancer
DOI: 10.1056/NEJMc24067502025
Journal article
Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia
DOI: 10.1002/cti2.70049
RECENT SCHOLARLY WORKS
2025
Journal article
Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial
DOI: 10.2196/653022024
Journal article
Safety and adherence to medications and self-care advice in oncology (SAMSON): pilot randomised controlled trial protocol
DOI: 10.1136/bmjopen-2023-0791222024
Journal article
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon
DOI: 10.1182/bloodadvances.2023011327